投稿信息
投稿信息
審稿周期
投稿命中率
審稿費用
暫無數據
版面費用
暫無數據
中國人發表比例
2023年中國人文章占該期刊總數量1.29% (2022年為10.26%)
自引率
4.2 %
年文章數
7065
作者需知
暫無數據
NCBI查詢
偏重的研究方向
期刊簡介
稿件收錄要求
稿件收錄要求
The Journal invites for review original papers dealing with interactions of chemicals with biological systems. All aspects of pharmacology and therapeutics are appropriate, but descriptive case reports without dose-response or mechanistic studies are not acceptable. Manuscripts dealing primarily with new methods will be reviewed only if data are presented showing that new or more reliable pharmacological information has been obtained with their use.
